As considered above, the BCR-ABLp210, BCR-ABLp190, and LMO2 oncogenes drive human CML, Ph+ B-cell ALL, and T-cell ALL. Here, BCR is linked to chronic myelogenous leukemia, BCR-ABL1 positive.